FDA Inspection 1300752 — Ferndale Laboratories, Inc.

Ferndale Laboratories, Inc. — FEI 1811212

The FDA completed an inspection of Ferndale Laboratories, Inc. on February 27, 2026 in Ferndale, MI. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 27, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ferndale, MI (United States)